全文获取类型
收费全文 | 1273篇 |
免费 | 122篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 58篇 |
妇产科学 | 16篇 |
基础医学 | 155篇 |
口腔科学 | 28篇 |
临床医学 | 209篇 |
内科学 | 294篇 |
皮肤病学 | 77篇 |
神经病学 | 60篇 |
特种医学 | 115篇 |
外科学 | 171篇 |
综合类 | 32篇 |
预防医学 | 82篇 |
眼科学 | 12篇 |
药学 | 30篇 |
肿瘤学 | 63篇 |
出版年
2023年 | 19篇 |
2021年 | 22篇 |
2020年 | 11篇 |
2019年 | 25篇 |
2018年 | 35篇 |
2017年 | 27篇 |
2016年 | 30篇 |
2015年 | 24篇 |
2014年 | 41篇 |
2013年 | 49篇 |
2012年 | 51篇 |
2011年 | 46篇 |
2010年 | 52篇 |
2009年 | 67篇 |
2008年 | 42篇 |
2007年 | 40篇 |
2006年 | 48篇 |
2005年 | 40篇 |
2004年 | 37篇 |
2003年 | 39篇 |
2002年 | 38篇 |
2001年 | 21篇 |
2000年 | 33篇 |
1999年 | 39篇 |
1998年 | 42篇 |
1997年 | 41篇 |
1996年 | 41篇 |
1995年 | 29篇 |
1994年 | 30篇 |
1993年 | 32篇 |
1992年 | 17篇 |
1991年 | 19篇 |
1990年 | 23篇 |
1989年 | 24篇 |
1988年 | 22篇 |
1987年 | 29篇 |
1986年 | 26篇 |
1985年 | 21篇 |
1984年 | 16篇 |
1983年 | 16篇 |
1982年 | 8篇 |
1981年 | 12篇 |
1980年 | 8篇 |
1979年 | 13篇 |
1978年 | 6篇 |
1977年 | 5篇 |
1976年 | 8篇 |
1975年 | 4篇 |
1973年 | 4篇 |
1972年 | 4篇 |
排序方式: 共有1404条查询结果,搜索用时 312 毫秒
51.
52.
Besides rickets and osteomalacia, the X-linked hypophosphatemic male mouse () presents with low serum calcium (Ca) and increased urinary hydroxyproline (OH-Pro) excretion, suggesting a parathyroid hormone (PTH)-stimulated bone resorption despite reduced magnesium (Mg) bone content. In this study, we have investigated by histochemical methods the state of bone resorption in 50-day-old untreated mice and the effects of 4 wk of Mg therapy or dietary lactose supplementation on bone formation and resorption. Mineral and skeletal changes were evaluated on serum, urinary and bone ash concentrations of Ca, phosphorus (P) and Mg, and by histomorphometric analysis of tetracycline double labeled undecalcified caudal vertebrae. The number of acid phosphatase stained chondroclasts and osteoclasts was lower than normal in untreated and was restored after Mg therapy while the osteoclastic surface was increased above normal. Accordingly, serum P and urinary Ca, P, Mg, cAMP and OH-Pro were increased while was unchanged. On the other hand, dietary lactose corrected serum Ca which probably suppressed PTH secretion since the renal P conservation was improved and the osteoclast number and the osteoclastic surface were decreased. Both treatments reduced the growthplate and osteoid seam thickness and increased the bone calcification rate. The results indicate that the low skeletal Mg present in partially impairs bone responsiveness to PTH since Mg therapy restored the osteoclastic bone resorption which secondarily provided new minerals for bone mineralization. The greater than normal bone resorption found in Mg and the decreased bone resorption observed in lactose treated animals indicate that the chronic hypocalcemia induces secondary hyperparathyroidism in mice. 相似文献
53.
G Jancso MT Jaberansari B Gasz Z Szanto B Cserepes E Rth 《Experimental & Clinical Cardiology》2004,9(1):21-25
OBJECTIVES:
To show that angiotensin-converting enzyme (ACE) inhibition potentiates subthreshold ischemic preconditioning (IPC) via the elevation of bradykinin activity, leading to a fully delayed cardioprotective response.METHODS:
On day 1 of the experiment, pigs were subjected to sham (group 1, controls) or IPC protocols. In groups 2 and 3, 4×5 min and 2×2 min of IPC, respectively, were elicited by occluding the left anterior descending coronary artery with percutaneous transluminal coronary angioplasty inflatable balloon catheter. Group 4 was subjected to the ACE inhibitor perindoprilate only. In group 5, the pigs were pretreated with perindoprilate (0.06 mg/kg) and then subjected to 2×2 min IPC. In group 6, intracoronary HOE 140 (a selective bradykinin B2 receptor antagonist) was added before the perindoprilateaugmented subthreshold (2×2 min) PC stimulus. On the second day, all animals underwent 40 min left anterior descending coronary artery ligation and 3 h reperfusion, followed by infarct size analysis using triphenyl tetrazolium chloride staining.RESULTS:
The rates of infarct size and risk zone were the following in the experimental groups: group 1, 42.8%; group 2,19.5% (P<0.05); group 3, ischemia/reperfusion (I/R) 33.4%; group 4, I/R 18.4% (P<0.05); group 5, I/R 31.2%; and group 6, I/R 36.3%. A significant increase of nuclear factor kappa B activation in groups 2 and 4 was seen.CONCLUSIONS:
Results confirm that ACE inhibitors do not give total pharmacological IPC, but they enhance the induction effect of small ischemic insults, which raises the ischemic tolerance of myocardium. It was determined that enhanced bradykinin activity leads to downstream nuclear factor kappa B activation in this model. 相似文献54.
55.
56.
57.
58.
59.
60.
Nilana MT Barros Raquel L Neves William N Addison Diego M Assis Monzur Murshed Adriana K Carmona Marc D McKee 《Journal of bone and mineral research》2013,28(3):688-699
X‐linked hypophosphatemia (XLH/HYP)—with renal phosphate wasting, hypophosphatemia, osteomalacia, and tooth abscesses—is caused by mutations in the zinc‐metallopeptidase PHEX gene (phosphate‐regulating gene with homologies to endopeptidase on the X chromosome). PHEX is highly expressed by mineralized tissue cells. Inactivating mutations in PHEX lead to distal renal effects (implying accumulation of a secreted, circulating phosphaturic factor) and accumulation in bone and teeth of mineralization‐inhibiting, acidic serine‐ and aspartate‐rich motif (ASARM)‐containing peptides, which are proteolytically derived from the mineral‐binding matrix proteins of the SIBLING family (small, integrin‐binding ligand N‐linked glycoproteins). Although the latter observation suggests a local, direct matrix effect for PHEX, its physiologically relevant substrate protein(s) have not been identified. Here, we investigated two SIBLING proteins containing the ASARM motif—osteopontin (OPN) and bone sialoprotein (BSP)—as potential substrates for PHEX. Using cleavage assays, gel electrophoresis, and mass spectrometry, we report that OPN is a full‐length protein substrate for PHEX. Degradation of OPN was essentially complete, including hydrolysis of the ASARM motif, resulting in only very small residual fragments. Western blotting of Hyp (the murine homolog of human XLH) mouse bone extracts having no PHEX activity clearly showed accumulation of an ~35 kDa OPN fragment that was not present in wild‐type mouse bone. Immunohistochemistry and immunogold labeling (electron microscopy) for OPN in Hyp bone likewise showed an accumulation of OPN and/or its fragments compared with normal wild‐type bone. Incubation of Hyp mouse bone extracts with PHEX resulted in the complete degradation of these fragments. In conclusion, these results identify full‐length OPN and its fragments as novel, physiologically relevant substrates for PHEX, suggesting that accumulation of mineralization‐inhibiting OPN fragments may contribute to the mineralization defect seen in the osteomalacic bone characteristic of XLH/HYP. © 2013 American Society for Bone and Mineral Research. 相似文献